Overview
Status
Active
Registry date
2021-08-23
Share capital
20,000.00 PLN
Registered address
Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Faten A Halawani – Management Board Member
Ghassan M Mahmoud – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Faten Khalil A Halawaniage 67 | 25 | $1,350.62 | 25% |
Ghassan Waheeb M Mahmoudage 67 | 75 | $4,051.86 | 75% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-06-12 | Address change (Ul. Juliana Smulikowskiego 4/212, 00-389, Warszawa → Warszawa) | |
| 2021-08-23 | Entered in the register |
FAQ
The main business activity of GWM Poland focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on August 23, 2021.
The headquarters is located at: Warszawa.
The share capital of the company is PLN 20,000 (approx. $5,402).
Last updated: 2026-06-12